Primary Hyperoxaluria Treatment Market Size, Share, Trends, Growth 2024-2032

The primary hyperoxaluria treatment market size was valued at USD 18.24 million in 2024, driven by advancements in diagnostic methods for better treatment outcomes. The market size is anticipated to grow at a CAGR of 3.67% during the forecast period of 2024-2032 to achieve a value of USD 25.25 million by 2032.Primary hyperoxaluria treatment focuses on reducing the excessive production of oxalate, a key factor in the condition. Therapies include medications like pyridoxine (vitamin B6) for specific subtypes and inhibitors of oxalate production like nitisinone. Aggressive fluid intake and a low-oxalate diet are commonly recommended to minimize oxalate buildup.